Your Source for Venture Capital and Private Equity Financings

Debut Closes $40M Series B Financing

2023-10-19
SAN DIEGO, CA, Debut has closed a total of $40 million in its Series B funding round.
Debut, a vertically integrated synthetic biology company that unlocks a new generation of cosmetic bioactive ingredients using the most advanced biomanufacturing approaches, announced that it will develop bio-identical and novel fragrance molecules, having closed a total of $40 million in its Series B funding led by BOLD, the venture capital fund of L'Oréal.

Debut is an unconventional innovation company, setting a new standard for the next generation of beauty. With breakthrough biotechnology, Debut's team of expert scientists and brand specialists work to develop novel bioactive skincare ingredients and products, including the launch of its first consumer brand through its scalable creation model. With a human-centric and climate-positive approach, Debut is committed to creating purposeful brands that push humanity forward.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors